These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 16004672)
21. Management of osteoporosis in a pre-menopausal woman. Bhalla AK Best Pract Res Clin Rheumatol; 2010 Jun; 24(3):313-27. PubMed ID: 20534366 [TBL] [Abstract][Full Text] [Related]
22. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Seeman E Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058 [TBL] [Abstract][Full Text] [Related]
23. [Contribution of bone quality to fracture risk]. Mori S Clin Calcium; 2004 Oct; 14(10):33-8. PubMed ID: 15577129 [TBL] [Abstract][Full Text] [Related]
24. PASSCLAIM - Bone health and osteoporosis. Prentice A; Bonjour JP; Branca F; Cooper C; Flynn A; Garabedian M; Müller D; Pannemans D; Weber P Eur J Nutr; 2003 Mar; 42 Suppl 1():I28-49. PubMed ID: 12664322 [TBL] [Abstract][Full Text] [Related]
25. Advanced imaging assessment of bone fragility in glucocorticoid-induced osteoporosis. Kalpakcioglu BB; Engelke K; Genant HK Bone; 2011 Jun; 48(6):1221-31. PubMed ID: 21320651 [TBL] [Abstract][Full Text] [Related]
26. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology, etiology, and diagnosis of osteoporosis. Lane NE Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873 [TBL] [Abstract][Full Text] [Related]
29. Bone strength and its determinants. Ammann P; Rizzoli R Osteoporos Int; 2003; 14 Suppl 3():S13-8. PubMed ID: 12730800 [TBL] [Abstract][Full Text] [Related]
30. Correlation of back pain, compression fracture and quadriceps muscle strength with bone mineral density in renal insufficiency patients. Terzibasioglu AM; Akarirmak U; Saridogan M; Tuzun S Eura Medicophys; 2005 Dec; 41(4):303-8. PubMed ID: 16474285 [TBL] [Abstract][Full Text] [Related]
31. Microarchitecture, the key to bone quality. Brandi ML Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv3-8. PubMed ID: 19783591 [TBL] [Abstract][Full Text] [Related]
32. [Progress in the treatment of osteoporosis]. Sugimoto T Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785 [TBL] [Abstract][Full Text] [Related]
33. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Delmas PD; Seeman E Bone; 2004 Apr; 34(4):599-604. PubMed ID: 15050889 [TBL] [Abstract][Full Text] [Related]
34. A comprehensive approach to fragility fractures. Rebolledo BJ; Unnanuntana A; Lane JM J Orthop Trauma; 2011 Sep; 25(9):566-73. PubMed ID: 21654529 [TBL] [Abstract][Full Text] [Related]
35. Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture? Li Z; Chines AA; Meredith MP J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):64-74. PubMed ID: 15615079 [TBL] [Abstract][Full Text] [Related]
36. Osteoporosis: is there a rational approach to fracture prevention? Lane N Bull NYU Hosp Jt Dis; 2006; 64(1-2):67-71. PubMed ID: 17121493 [TBL] [Abstract][Full Text] [Related]
37. The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy. Epstein S Mayo Clin Proc; 2005 Mar; 80(3):379-88. PubMed ID: 15757020 [TBL] [Abstract][Full Text] [Related]
38. One fracture is enough! Experience with a prospective and consecutive osteoporosis screening program with 239 fracture patients. Astrand J; Thorngren KG; Tägil M Acta Orthop; 2006 Feb; 77(1):3-8. PubMed ID: 16534695 [TBL] [Abstract][Full Text] [Related]
39. [Pathogenesis of fracture will be important in the research work of osteoporosis]. Shiraki M Nihon Rinsho; 2006 Sep; 64(9):1597-604. PubMed ID: 16972665 [TBL] [Abstract][Full Text] [Related]
40. The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover. Frost ML; Cook GJ; Blake GM; Marsden PK; Fogelman I J Clin Densitom; 2007; 10(1):46-54. PubMed ID: 17289526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]